Market Overview:
The global glucometer market is expected to grow at a CAGR of 6.5% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of diabetes, technological advancements in glucometers, and rising demand for home-based blood glucose monitoring devices. Based on type, the photoelectric type blood glucometer segment is expected to account for the largest share of the global glucometer market in 2018. This segment is also projected to grow at a CAGR of 7% from 2018 to 2030. The large share and high growth rate of this segment can be attributed to its growing popularity among consumers owing to its accuracy and convenience features. Based on application, household users are expected account for the largest share of the global glucometer market in 2018 followed by hospital users.
Product Definition:
A glucometer is a medical device used to measure the blood glucose level. This is important for people with diabetes because they need to keep track of their blood sugar levels in order to make sure they are staying in their target range.
Photoelectric Type Blood Glucometer:
The photoelectric type blood glucometer is a new-fangled glucometer that makes use of the photoelectric effect to measure blood sugar. The device works by generating and detecting the presence of light in various wavelengths which are then absorbed by hemoglobin in human body tissues, fluids, and other objects to give an estimation of sugar level in the body.
Electrodes Type Glucometer:
An electrodes type glucometer is a device used to measure the blood sugar level. It consists of two test sticks, one of which is used to draw blood from the patient and analyze the reading obtained. The other stick is used as an indicator for measuring glucose levels in samples of plasma, serum, and whole blood.
Application Insights:
The household segment dominated the global market in 2017. The rising awareness about diabetes and its symptoms has led to an increased demand for meters, especially glucometers that are user-friendly and can be used without any professional help. Moreover, technological advancements have made it easier for people with diabetes to use these devices at home.
Hospital is expected to be the fastest-growing application segment over the forecast period owing to increasing investments by governments in healthcare infrastructure coupled with rising prevalence of target diseases such as heart disease, cancer, stroke and diabetes which require frequent blood glucose monitoring during treatment. In addition, growing investments by manufacturers in R&D pertaining to new product development is anticipated to boost growth over the coming years.
Regional Analysis:
North America dominated the global market in 2017 owing to the presence of a large number of key players such as Abbott, Roche and Johnson & Johnson. The increasing prevalence of diabetes is also one of the major factors driving this region’s growth. According to CDC, around 29 million people in North America have diabetes; however, an estimated 87 million people are living with pre-diabetes condition that may lead to type 2 diabetes over time.
Asia Pacific region is expected to grow at a lucrative rate during the forecast period due its developing economy and increasing patient pool suffering from obesity and related diseases such as heart diseases, stroke etc. Moreover, government initiatives for creating awareness regarding blood glucose monitoring along with proper treatment for diabetic patients will drive this regional market further.
Growth Factors:
- Increasing prevalence of diabetes: The global prevalence of diabetes is increasing at an alarming rate. This is primarily due to the changing lifestyle and dietary habits of people across the world. As a result, there is an increased demand for glucometers and other diabetes-related devices and products.
- Technological advancements: The glucometer market is witnessing rapid technological advancements, with new products being launched regularly. This has resulted in increased competition among manufacturers, which in turn has led to lower prices and better features in glucometers.
- Growing awareness about diabetes: There is growing awareness about diabetes among people all over the world, thanks to various campaigns by health organizations as well as governments worldwide. This has led to an increase in demand for glucometers and related devices/products from both patients as well as healthcare professionals alike..
Scope Of The Report
Report Attributes
Report Details
Report Title
Glucometer Market Research Report
By Type
Photoelectric Type Blood Glucometer, Electrodes Type Glucometer
By Application
Household, Hospital, Clinic
By Companies
ACCU-CHEK, Johnson & Johnson, Abbott, Bayer, OMRON, ARKRAY, ACON, Sannuo, Bioland, Nova, Yuwell, YiCheng, GRACE, Andon, BIONIME
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
230
Number of Tables & Figures
161
Customization Available
Yes, the report can be customized as per your need.
Global Glucometer Market Report Segments:
The global Glucometer market is segmented on the basis of:
Types
Photoelectric Type Blood Glucometer, Electrodes Type Glucometer
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Household, Hospital, Clinic
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- ACCU-CHEK
- Johnson & Johnson
- Abbott
- Bayer
- OMRON
- ARKRAY
- ACON
- Sannuo
- Bioland
- Nova
- Yuwell
- YiCheng
- GRACE
- Andon
- BIONIME
Highlights of The Glucometer Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Photoelectric Type Blood Glucometer
- Electrodes Type Glucometer
- By Application:
- Household
- Hospital
- Clinic
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Glucometer Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A glucometer is a medical device that measures blood sugar levels.
Some of the major companies in the glucometer market are ACCU-CHEK, Johnson & Johnson, Abbott, Bayer, OMRON, ARKRAY, ACON, Sannuo, Bioland, Nova, Yuwell, YiCheng, GRACE, Andon, BIONIME.
The glucometer market is expected to grow at a compound annual growth rate of 6.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Glucometer Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Glucometer Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Glucometer Market - Supply Chain
4.5. Global Glucometer Market Forecast
4.5.1. Glucometer Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Glucometer Market Size (000 Units) and Y-o-Y Growth
4.5.3. Glucometer Market Absolute $ Opportunity
5. Global Glucometer Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Glucometer Market Size and Volume Forecast by Type
5.3.1. Photoelectric Type Blood Glucometer
5.3.2. Electrodes Type Glucometer
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Glucometer Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Glucometer Market Size and Volume Forecast by Application
6.3.1. Household
6.3.2. Hospital
6.3.3. Clinic
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Glucometer Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Glucometer Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Glucometer Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Glucometer Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Glucometer Demand Share Forecast, 2019-2026
9. North America Glucometer Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Glucometer Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Glucometer Market Size and Volume Forecast by Application
9.4.1. Household
9.4.2. Hospital
9.4.3. Clinic
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Glucometer Market Size and Volume Forecast by Type
9.7.1. Photoelectric Type Blood Glucometer
9.7.2. Electrodes Type Glucometer
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Glucometer Demand Share Forecast, 2019-2026
10. Latin America Glucometer Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Glucometer Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Glucometer Market Size and Volume Forecast by Application
10.4.1. Household
10.4.2. Hospital
10.4.3. Clinic
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Glucometer Market Size and Volume Forecast by Type
10.7.1. Photoelectric Type Blood Glucometer
10.7.2. Electrodes Type Glucometer
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Glucometer Demand Share Forecast, 2019-2026
11. Europe Glucometer Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Glucometer Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Glucometer Market Size and Volume Forecast by Application
11.4.1. Household
11.4.2. Hospital
11.4.3. Clinic
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Glucometer Market Size and Volume Forecast by Type
11.7.1. Photoelectric Type Blood Glucometer
11.7.2. Electrodes Type Glucometer
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Grwth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Glucometer Demand Share, 2019-2026
12. Asia Pacific Glucometer Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Glucometer Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Glucometer Market Size and Volume Forecast by Application
12.4.1. Household
12.4.2. Hospital
12.4.3. Clinic
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Glucometer Market Size and Volume Forecast by Type
12.7.1. Photoelectric Type Blood Glucometer
12.7.2. Electrodes Type Glucometer
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Glucometer Demand Share, 2019-2026
13. Middle East & Africa Glucometer Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Glucometer Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Glucometer Market Size and Volume Forecast by Application
13.4.1. Household
13.4.2. Hospital
13.4.3. Clinic
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Glucometer Market Size and Volume Forecast by Type
13.7.1. Photoelectric Type Blood Glucometer
13.7.2. Electrodes Type Glucometer
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Glucometer Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Glucometer Market: Market Share Analysis
14.2. Glucometer Distributors and Customers
14.3. Glucometer Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. ACCU-CHEK
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Johnson & Johnson
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Abbott
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Bayer
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. OMRON
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. ARKRAY
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. ACON
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Sannuo
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Bioland
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Nova
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Yuwell
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. YiCheng
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. GRACE
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Andon
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. BIONIME
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
